Abstract :
Diabetes mellitus is a group of metabolic diseases with characteristics of
hyperglycemia that occur due to abnormal insulin secretion, insulin action, or
both. Indonesia is ranked fourth in the number of people with diabetes mellitus in
the world after the United States, India, and China. Based on data known that
about 90% of DM patients to reduce and control blood glucose levels near the
normal range can be given oral antidiabetic therapy, insulin administration or
combination of both. The purpose of this study was to find out the description of
insulin use in the treatment of DM patients and the suitability of using formulary
insulin in the Inpatient Pharmacy Installation of Panti Waluyo Hospital. This
study was a descriptive study conducted in a retrospective. The population was
344 medical peer-reviewed sheets and the number of research samples 185 taken
with non propability sampling techniques. Based on the results of the study during
the period January-June 2018, 185 people(100%) of the study subjects suffered
from type 2 diabetes mellitus and according to the Hospital formulary, there were
more female diabetes mellitus patients than male patients,52% female patients
and male patients 48%. All patients are diagnosed with type 2 diabetes mellitus.
The comorbidities in patients with diabetes mellitus were 30,81% hypertension
and stroke, 11,90% diabetes mellitus with HHD (Heart Hypertension Disease),
8,65% diabetes mellitus with CRF (Chronic Renal Failure), diabetes mellitus with
CKD (Chronic Kidney Disease) 11.89 %, Patients received single insulin therapy
as much as 92.43% and combination insulin therapy as much as 7.57%.